» AJMCtv Interviews - AJMC.com Managed Markets Network
17/08/19 10:14 from BRCA - Google News
AJMCtv Interviews    AJMC.com Managed Markets Network AJMC ® TV interviews let you catch up on what's new and important about changes in healthcare, with insights from key decision makers—from the clinician, ...

» New targets, treatment strategies create 'exciting time' in triple-negative breast cancer - Healio
17/08/19 08:11 from BRCA - Google News
New targets, treatment strategies create 'exciting time' in triple-negative breast cancer    Healio Although breast cancer mortality has declined by 40% over the past several decades, more than 40000 women will die of the disea...

» Seattle scientist summits Mt. Kilimanjaro to fight cancer, raise money - KOMO News
16/08/19 21:23 from BRCA - Google News
Seattle scientist summits Mt. Kilimanjaro to fight cancer, raise money    KOMO News Imagine hiking at an altitude of 17000 to 18000 feet for hours. You're exhausted walking back to camp, but then you're greeted with 100 or more...

» Maintenance Therapy: PARP Inhibitor or Bevacizumab - OncLive
16/08/19 21:04 from BRCA - Google News
Maintenance Therapy: PARP Inhibitor or Bevacizumab    OncLive Bradley Monk, MD, FACOG, FACS, leads a discussion on the meta-analysis comparing bevacizumab to PARP inhibitors as maintenance therapy in patients with ...

» Metastatic Pancreas Cancer Treatment Approaches - OncLive
16/08/19 20:37 from BRCA - Google News
Metastatic Pancreas Cancer Treatment Approaches    OncLive Experts in pancreatic cancer share their personal insights about frontline therapy for metastatic disease and the nuances involved in selecting the best regimen ...

» AstraZeneca Calquence Gets FDA's Breakthrough Status for CLL - Nasdaq
16/08/19 11:33 from BRCA - Google News
AstraZeneca Calquence Gets FDA's Breakthrough Status for CLL    Nasdaq AstraZeneca AZN announced that the FDA has granted Breakthrough Therapy Designation (BTD) to its leukemia drug Calquence for chronic lymphocytic.

» With Over USD 4 Billion in Capital Investment, the Synthetic Lethality-based Drugs Market is Poised to Witness a Rapid Growth, Claims Roots Analysis - P&T Community
16/08/19 11:00 from BRCA - Google News
With Over USD 4 Billion in Capital Investment, the Synthetic Lethality-based Drugs Market is Poised to Witness a Rapid Growth, Claims Roots Analysis    P&T Community Advances in screening technologies have enabled the identific...

» Understanding the Role of the OB/GYN in Evaluating Hereditary Cancer Risk - AJMC.com Managed Markets Network
16/08/19 10:56 from BRCA - Google News
Understanding the Role of the OB/GYN in Evaluating Hereditary Cancer Risk    AJMC.com Managed Markets Network A woman who receives a diagnosis of breast or ovarian cancer or learns she faces an increased cancer risk because of ...

» AstraZeneca Calquence Gets FDA's Breakthrough Status for CLL - Yahoo Finance
16/08/19 10:33 from BRCA - Google News
AstraZeneca Calquence Gets FDA's Breakthrough Status for CLL    Yahoo Finance The Breakthrough Therapy Designation (BTD) to AstraZeneca's (AZN) Calquence is based on positive interim data from two phase III studies.

» Breast Cancer Gene Mutation Also Increases Risk Of Type Of Childhood Cancer - Forbes
16/08/19 07:21 from BRCA - Google News
Breast Cancer Gene Mutation Also Increases Risk Of Type Of Childhood Cancer    Forbes Women with mutations in the BRCA1 or BRCA2 genes are well known to have an increased risk of developing both breast and ovarian cancer. As we...

Powered by Feed Informer